A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells

AUTOR(ES)

Dimitroff, Charles J.

FONTE

The National Academy of Sciences

RESUMO

We previously have obtained operational evidence of a hematopoietic cell L-selectin ligand expressed on normal human hematopoietic cells and on leukemic blasts. Using a technique developed in our laboratory for analyzing and identifying adhesion molecules, we show here that hematopoietic cell L-selectin ligand is a specialized glycoform of CD44. This L-selectin ligand activity of CD44 requires sialofucosylated N-linked glycans and is sulfation-independent. These data provide important insights on the structural biology of CD44 and reveal a role for this protein as an L-selectin ligand on human hematopoietic cells.

Documentos Relacionados

• Expression of l-Selectin (CD62L), CD44, and CD25 on Activated Bovine T Cells
• Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice.
• Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin
• Tyrosine replacement in P-selectin glycoprotein ligand-1 affects distinct kinetic and mechanical properties of bonds with P- and L-selectin
• Chemically distinct transition states govern rapid dissociation of single L-selectin bonds under force